Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Prophylaxis for HBV in Lymphoma
NCT01765231Phase 4Unknown
- Sponsor
- Peking University
- Start
- Jan 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in hepatitis B (HBV), sponsored by Peking University. Status: unknown.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01765231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765231.